Exercise-Induced Myostimulin Enhances Muscle Function in Health and Disease
Frank Hillger, Angela Furrer, Stefan Melly, Sabrina Seddik et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Meike Scharenberg
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
32Publications signalées
1075Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Escherichia coli research studiesGlycosylation and Glycoproteins ResearchMonoclonal and Polyclonal Antibodies ResearchUrinary Tract Infections ManagementAntibiotic Resistance in Bacteria
Publications récentes
Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1
Johanna R. Abend, Atul Sathe, Matthias B. Wrobel, Mark Knapp et autres
20 citationsAmerican Journal of Transplantation
Data from Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies
Haihui Lu, Ryan D. Molony, Dongshu Chen, Sunyoung Jang et autres
0 citations
Supplementary Data from Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies
Haihui Lu, Ryan D. Molony, Dongshu Chen, Sunyoung Jang et autres
0 citations
Supplementary Figures from Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies
Haihui Lu, Ryan D. Molony, Dongshu Chen, Sunyoung Jang et autres
0 citations
Supplementary Data from Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies
Haihui Lu, Ryan D. Molony, Dongshu Chen, Sunyoung Jang et autres
0 citations
Supplementary Figures from Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies
Haihui Lu, Ryan D. Molony, Dongshu Chen, Sunyoung Jang et autres
0 citations
Data from Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies
Haihui Lu, Ryan D. Molony, Dongshu Chen, Sunyoung Jang et autres
0 citations
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events
Anette Karle, Matthias B. Wrobel, Stephan Koepke, Michael Gutknecht et autres
38 citationsScience Translational Medicine
Preclinical Characterization of MAU868, a Novel Neutralizing Antibody Targeting BK Virus
Atul Sathe, Mark Knapp, Lihong Zhao, Peter Kim et autres
1 citationJournal of the American Society of Nephrology
Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies
Haihui Lu, Ryan D. Molony, Dongshu Chen, Sunyoung Jang et autres
9 citationsMolecular Cancer Therapeutics
Abstract C028: Discovery and characterization of next generation monoclonal antibodies targeting the inhibitory Fc gamma receptor CD32b for the treatment of B and plasma cell malignancies
Haihui Lu, Dongshu Chen, Sunyoung Jang, Babette Wolf et autres
0 citationsMolecular Cancer Therapeutics
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.